Javed Butler, MD, MPH, MBA
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei de...
Piotr Ponikowski, MD, PHD, FESC, FHFA
Gerasimos Filippatos, MD, FESC, FHFA
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
James A. Underberg, MD, MS, FACP, FNLA
Update on ASCVD Risk Assessment and Management
George Bakris, MD
Matthew R. Weir, MD
Faiez Zannad, MD, PhD
Potassium Management Made Easy
Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
Mikhail Kosiborod, MD
Management of Heart Failure: Time to Consider New Options?
Michel Farnier, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl ...
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
Robert J. Mentz, MD
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Suneet Mittal, MD FACC FHRS
Aysha Arshad MD, FACC, FHRS, FAHA
Telemedicine During COVID-19 Outbreak
Brian P. McDonough, MD, FAAFP
How Primary Care Clinicians on the Frontline Are Managing Patients During the COVID-19 Pandemic
How Primary Care Clinicians on the Frontline Are Managing Patients During the...
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
C. Michael Gibson, MD, MS
COVID-19 & Cardiovascular Considerations
Jay L. Koyner, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
John A. Kellum, MD, MCCM
Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
Matt Birnholz, MD
Joshua D. Lee MD, MSc
Opioid Use Disorder: Expanding Access to Treatment
Thomas C. Wright, Jr., MD
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Pa...
Leonard H. Calabrese, DO
John R. Tesser, MD
Pinpointing the Top Questions about Biosimilars in Rheumatology